SGLT2 Inhibitors Appear Protective in CKD, Kidney Transplantation
SGLT2 inhibitors are associated with an initial dip in eGFR, so nephrologists need to monitor kidney function.
Diagnosis & Disease Information
Obesity in Glomerulonephritis May Increase Risk for ESKD
Obesity rates in glomerular disease have multiplied more than 10-fold over the last 40 years.
Antihypertensive Meds Recalled Due to Nitrosamine Impurity
N-nitroso-irbesartan is a probable human carcinogen based on results from laboratory tests.
Researchers Study the Potential Impact of Dapagliflozin on Diabetic Kidney Disease
A large multinational study examined the potential impact of dapagliflozin on kidney disease in people with type 2 diabetes.
Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
Frailty Ups Risk for Urinary Tract Infections in Patients With Diabetes, CKD
More severe frailty predicted a higher risk of UTIs.
Free Fatty Acids Associated With Rapid Decline in Glomerular Filtration Rates in Type 1 Diabetes
Researchers identified lipidomic predictors of rapid decline of kidney function in individuals with type 1 diabetes.
Dapagliflozin Safe, Effective in Advanced Chronic Kidney Disease
Dapagliflozin’s benefits among patients with stage 4 CKD were consistent with those observed in the larger DAPA-CKD cohort with stage 2-3 CKD.
High iPTH Linked With Cardiovascular Outcomes in Diabetic Kidney Disease
Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.
Kerendia Approved to Reduce CKD Progression, CV Risk in Patients With Diabetic Kidney Disease
The approval was based on data from the phase 3 FIDELIO-DKD trial.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...